First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 64.27 USD 0.3% Market Closed
Updated: Jun 1, 2024

Gilead Sciences Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gilead Sciences Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$10.7B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
3%
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$2.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.9B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-15%
Moderna Inc
NASDAQ:MRNA
Retained Earnings
$12.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$11.2B
CAGR 3-Years
95%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$28B
CAGR 3-Years
33%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Gilead Sciences Inc's Retained Earnings?
Retained Earnings
10.7B USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Retained Earnings amounts to 10.7B USD.

What is Gilead Sciences Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
3%

Over the last year, the Retained Earnings growth was -30%. The average annual Retained Earnings growth rates for Gilead Sciences Inc have been -10% over the past three years , -11% over the past five years , and 3% over the past ten years .